Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1073 | 974 | 1153 | 1075 | 1236 | 2005 |
Fund Return | 7.28% | -2.62% | 15.3% | 2.44% | 4.32% | 7.2% |
Place in category | 270 | 325 | 194 | 189 | 129 | 27 |
% in Category | 73 | 83 | 53 | 57 | 45 | 13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FC Responsible Global Equity Fund 2 | 1.33B | 16.06 | 3.68 | 11.96 | ||
FC Responsible Global Equity 1 Acc | 1.33B | 15.23 | 2.89 | 11.05 | ||
FC Responsible Global Equity 1 Inc | 1.33B | 15.06 | 2.68 | 10.91 | ||
FC Responsible Global Equity 2 Acc | 1.33B | 16.04 | 3.69 | 11.98 | ||
FC Responsible Global Equity 4 Inc | 1.33B | 16.81 | 4.44 | 12.75 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artemis UK Select Fund I Acc | 1.77B | 24.83 | 12.40 | 9.69 | ||
Fidelity Special Situations | 243.13M | 15.73 | 8.17 | 6.91 | ||
Fidelity Special Situations Fund W | 2.41B | 16.52 | 8.98 | 7.72 | ||
Artemis UK Select Fund G Inc GBP | 750.74M | 20.04 | 8.70 | - | ||
Artemis UK Select Fund R Acc | 211.3M | 19.01 | 7.59 | 8.68 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.85 | 10,830.0 | +0.71% | |
Unilever | GB00B10RZP78 | 5.10 | 54.52 | +0.52% | |
Experian | GB00B19NLV48 | 3.39 | 3,437.0 | -0.55% | |
Relx | GB00B2B0DG97 | 3.05 | 3,790.00 | +0.40% | |
National Grid | GB00BDR05C01 | 2.88 | 936.80 | +0.52% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review